Townsend Letter The Examiner of Alternative Medicine
Alternative Medicine Conference Calendar
Check recent tables of contents


From the Townsend Letter
August/September 2007


EFAs, Oxygenation, and Cancer Prevention:
A New Solution
by Brian Scott Peskin, BSEE

Search this site

Page 1, 2

Clinical Results with the Peskin Protocol
Physicians utilizing the Peskin Protocol report significant improvements in patient outcomes across a broad spectrum of conditions.

"The Hidden Story of Cancer has provided a great breakthrough in the treatment of our cancer patients. The addition of 5-725 mg Peskin Protocol EFA capsules t.i.d. along with our protocol has brought a dramatic difference; unbelievable and rapid improvement:

  • Patient 1: 80-lb female with stage III lung cancer was in full remission in 90 days.
  • Patient 2: Two inoperable brain tumors (1 cm), unable to speak or navigate - had 40% reduction of both tumors in 60 days. Patient is able to walk and speak almost normally.
  • Patient 3: 8cm x 3 cm liver tumor told by his physician he had 30 days survival time. In 60 days of therapy, patient gained 30 pounds, 80% of tumor had calcified. Patient felt strong enough to return to work.
  • Patient 4: P.A.D. unable to walk more than 30 feet; with seven days of Peskin Protocol EFAs, she could walk four blocks.

"In ten days time, one can see a physical improvement in patient condition. We believe Peskin Protocol EFAs are the ‘missing link' in cancer therapy. The cost of treating our patients has dropped from $20,000 (US) per month to $1,500 per month by eliminating the use of eight IVs daily. We saw no side effects. Within two weeks, patients typically see a great physical and mental improvement."

Bernardo C. Majalca, ND
Stage 4 Cancer Researcher and Consultant
San Diego, California

"I have been using the Peskin Protocol EFAs (YES brand) for the last five months. I have had excellent reports from patients. Previously, I was recommending fish oil to almost all my patients. Some improved, specifically those with joint pains and heart disease. However, I did not see any improvement in my diabetic/HTN patients or those w/dermatologic problems. In fact, the latter group actually got worse. These patients had eczematous type rashes and psoriasis.

"After reviewing Brian's data regarding the concentration ratios of parent Omega 6 to parent Omega 3 in various tissues, it all made sense – five out of six of my worst dermatologic cases showed good to very good improvement in as little as three months with Peskin Protocol.

"Just taking Omega 3 alone (flax or fish oil) without regard to the appropriate balance can adversely affect diabetic patients. This was proven in two of my patients. These patients kept meticulous records regarding their blood sugars and the effect of diet on their glucose levels. Without changing their diets, they noticed significant elevations in the glucose levels after Omega 3 fatty acids for three to four months; one pt. had an increase of 40 points.

"After starting the YES balanced blend of parent Omega 6 and 3, not only did their BS normalize to more normal values, but they felt better overall and both commented that their energy level improved.

"Use of the Peskin Protocol in clinical practice has made a strong believer out of me, and I will continue to recommend this product to ALL my patients and refer them to Peskin's research for more information."

Angelo A. Della Pietra, MD, DO
Family and Integrative Medicine, Poughkeepsie, New York

"Having implemented EFA supplementation for over 25 years, clinical results were mediocre until I began using the Peskin Protocol. Dr. Rudin's work with flax oil was important but lacked clinical effectiveness; likewise with Horrobin regarding GLA from Borage, Black Currant, and Evening Primrose oils. Unlike the studies suggested, fish oil, too, was disappointing. Finally, I read The Hidden Story of Cancer which introduces the Peskin Protocol. Once implemented, I experienced clinical success.

"Although Brian's book deals extensively, but not exclusively, with cancer prevention, utilizing his protocol I have seen positive results (dermatological, cardiovascular, pediatric, and neurological) in over 100 of my patients."

Abram Ber, MD
Preventive Medicine/Homeopathic Physician

"As a practicing cardiologist, I have a strong interest in both the treatment and prevention of cardiovascular disease. As Brian details, the paramount discovery by Otto Warburg regarding oxygenation must also be considered the most important physiologic discovery in the cardiovascular disease arena. Given the understanding of Warburg's principles, as amplified and clarified by Brian, I have been enabled and am encouraged to incorporate this information in the form of "Nutritional Life Style" recommendations for my patients. Brian has advanced the basic science principles of Warburg into a practical, cost-effective formula – the Peskin Protocol – for patient care utilizing an increased scientific understanding of Omega 6 and Omega 3 essential fatty acid ratios.

"For those patients in my practice, and others I am aware of (100s), willing to embrace these basic principles, I have seen clinical improvement and success without adverse effects. Brian Peskin, in my opinion, has diligently and carefully "teased out" from the available, published scientific data base the links necessary to explain, understand, and help combat the most prominent cardiovascular disease state faced by patients."

David N. Sim, MD
Cardiologist, Boise, Idaho

About the Author
Brian Scott Peskin earned his Bachelor of Science degree in Electrical Engineering from Massachusetts Institute of Technology (MIT) in 1979. He founded the field of Life-Systems Engineering Science in 1995. Brian was appointed an adjunct professor at Texas Southern University in the Department of The Hidden Story of CancerPharmacy and Health Sciences for 1998-1999. Today, he is an independent researcher, exclusively devoting the last five years to the cause and solution of cancer.

This article is based on information in The Hidden Story of Cancer, written by Brian Peskin with clinical researcher Amid Habib, MD, FAAP, FACE (reviewed in this issue of Townsend Letter). The book is available from Pinnacle Press, P.O. Box 56507, Houston, Texas 77256, USA, or by phoning 1-800-456-9941 (toll-free in North America) or +1-713-979-0065 internationally. For more information, visit


1. Weinberg RA. One Renegade Cell: How Cancer Begins. New York: Basic Books; 1998:64.
2. Harris H, Miller OJ, Klein G, Worst P, Tachibana T. Suppression of malignancy by cell fusion. Nature. 1969;223:363-368.
3. Berger E. Cancer: looking beyond mutations. Houston Chronicle. June 27, 2005:1.
4. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001;285:769-776, 799-801.
5. Epstein S, Bertell R, Seaman B. Dangers and unreliability of mammography: Breast examination is a safe, effective, and practical alternative. Int Journal Health Services. 2001;31:605-615.
6. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999;340:169-176.
7. Levin B. Dietary intake and occurrence of colorectal adenoma. Lancet. 2000;356:1286-1287, 1300-1306.
8. Calder PC. Omega-3 polyunsaturated fatty acids, inflammation and immunity. The International Society for the Study of Fatty Acids and Lipids (ISSFAL) 4th Congress, June 4-9, 2000, Tsukuba, Japan.
9. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk. JAMA. 2006;295:403-415.
10. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega-3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752-760.
11. Shephard TH, Pyne GE, Kirschvink JF, McLean M. Soybean goiter: Report of three cases. New Engl J Med. 1960;262:1099-1103.
12. Bowman DE. Differentiation of soy bean antitryptic factors. Proceed Soc Exp Biol Med. 1946;63:547.
13. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:629-642.
14. Warburg O. The prime cause and prevention of cancer (Lindau Lecture). Revised. Würzburg, Germany: Konrad Triltsch, 1969. (English Edition, Dean Burk, National Cancer Institute, Bethesda, Maryland, USA.) Available at: Accessed August 11, 2006.
15. Goldblatt H, Cameron G. Induced malignancy in cells from rat myocardium subjected to intermittent anaerobiosis during long propagation in vitro. J Exp Med. 1953;97:525-552.
16. Malmgren, RA, Flanigan CC. Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res. 1955;15:473-478.
17. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 1997;38:285-290.
18. Hockel M, Knoop C, Schlenger K, et al. Intratumoral P02 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993;26:45-50.
19. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56:941-943.
20. Campbell IM, Crozier DN, Caton RB. Abnormal fatty acid composition and impaired oxygen supply in cystic fibrosis patients. Pediatrics. 1976;57:480-486.
21. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's Illustrated Biochemistry. 26th edition. New York: McGraw-Hill; 2003.
22. Meisenberg G, Simmons WH. Principles of Biomedical Chemistry. 1st edition. New York: Mosby; 1998.
23. Sinclair HM. Prevention of coronary heart disease: the role of essential fatty acids. Postgrad Med J. 1980;56:579-584.
24. Sinclair HM. Essential fatty acids in perspective. Hum Nutrit. 1984;38C:245-260.
25. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci. 2001;16:159-65; discussion 215-221.
26. Andersson A, Sjödin A, Hedman A, Olsson R, Vessby B. Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men. Am J Physiol Endocrinol Metab. 2000;279:E744-E751.
27. Chapkin RS, Ziboh VA, Marcelo CL, Voorhees JJ. Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation. J Lipid Res. 1986;27:945-954.
28. Garaulet M, Pérez-Llamas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74:585-591.
29. Burns CP, Luttenegger DG, Dudley DT, Buettner GR, Spector AA. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells. Cancer Research. 1979;39:1726-1732.
30. Sinclair AJ, Attar-Bashi NM, Li D. What is the role of alpha-linolenic acid for mammals? Lipids. 2002;37:1113-1123.
31. Pawlosky RJ, Hibbeln JR, Lin Y, et al. Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am J Clin Nutr. 2003;77:565-572.
32. Lands WEM, Morris A, Libelt B. Quantitative effects of dietary polyunsaturated fats on the composi-tion of fatty acids in rat tissues. Lipids. 1990;25:505-551.

Page 1, 2

Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine magazine, which is published 10 times each year.

Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices

Once you find the magazines you'd like to order, please use our convenient form, e-mail, or call 360.385.6021 (PST).


Who are we? | New articles | Featured topics |
Tables of contents
| Subscriptions | Contact us | Links | Classifieds | Advertise | Alternative Medicine Conference Calendar | Search site | Archives |
EDTA Chelation Therapy | Home


© 1983-2007 Townsend Letter for Doctors & Patients
All rights reserved.
Website by Sandy Hershelman Designs

August 31, 2007

Order back issues
Advertise with TLDP!
Visit our pre-2001 archives

Special Limited Edition on Amazon

Now $39.95
direct from